Filing Details

Accession Number:
0001628280-24-049794
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-03 17:26:53
Reporting Period:
2024-11-29
Accepted Time:
2024-12-03 17:26:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC Services-Offices & Clinics Of Doctors Of Medicine (8011) 043705970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2037547 M. Fernando Rodrigues C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
President Of Betterhelp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-29 21,964 $0.00 21,964 No 4 M Direct
Common Stock Disposition 2024-12-02 7,873 $11.93 14,091 No 4 S Direct
Common Stock Disposition 2024-12-03 14,091 $11.07 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2024-11-29 21,964 $0.00 21,964 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
43,930 No 4 M Direct
Footnotes
  1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  3. Represents the weighted average price of transactions ranging from $11.07 to $11.085, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
  4. On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.